SOPB_SALDU
ID SOPB_SALDU Reviewed; 561 AA.
AC O34105; Q9L6X6;
DT 11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT 01-JAN-1998, sequence version 1.
DT 25-MAY-2022, entry version 60.
DE RecName: Full=Inositol phosphate phosphatase SopB;
DE EC=3.1.3.-;
DE AltName: Full=Effector protein SopB;
GN Name=sopB; Synonyms=sigD;
OS Salmonella dublin.
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC Enterobacteriaceae; Salmonella.
OX NCBI_TaxID=98360;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-15 AND 55-67, AND
RP SUBCELLULAR LOCATION.
RC STRAIN=2229;
RX PubMed=9364916; DOI=10.1111/j.1365-2958.1997.mmi525.x;
RA Galyov E.E., Wood M.W., Rosqvist R., Mullan P.B., Watson P.R., Hedges S.,
RA Wallis T.S.;
RT "A secreted effector protein of Salmonella dublin is translocated into
RT eukaryotic cells and mediates inflammation and fluid secretion in infected
RT ileal mucosa.";
RL Mol. Microbiol. 25:903-912(1997).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=2229;
RX PubMed=9723926; DOI=10.1046/j.1365-2958.1998.00984.x;
RA Wood M.W., Jones M.A., Watson P.R., Hedges S., Wallis T.S., Galyov E.E.;
RT "Identification of a pathogenicity island required for Salmonella
RT enteropathogenicity.";
RL Mol. Microbiol. 29:883-891(1998).
RN [3]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 97-529.
RX PubMed=11200542; DOI=10.1016/s1438-4221(00)80009-0;
RA Prager R., Mirold S., Tietze E., Strutz U., Knuppel B., Rabsch W.,
RA Hardt W.-D., Tschape H.;
RT "Prevalence and polymorphism of genes encoding translocated effector
RT proteins among clinical isolates of Salmonella enterica.";
RL Int. J. Med. Microbiol. 290:605-617(2000).
RN [4]
RP FUNCTION, AND MUTAGENESIS OF CYS-460.
RC STRAIN=2229;
RX PubMed=9826652; DOI=10.1073/pnas.95.24.14057;
RA Norris F.A., Wilson M.P., Wallis T.S., Galyov E.E., Majerus P.W.;
RT "SopB, a protein required for virulence of Salmonella dublin, is an
RT inositol phosphate phosphatase.";
RL Proc. Natl. Acad. Sci. U.S.A. 95:14057-14059(1998).
CC -!- FUNCTION: Converts phosphatidylinositol 3,4,5-trisphosphate (PtdIns
CC 3,4,5-P3) to PtdIns 3-P and prevents the transition of PtdIns 3-P to
CC PtdIns 3,5-P2. It is one of the known effectors injected by Salmonella
CC into the host cell and is required for invasion and for an efficient
CC generation and maintenance of Salmonella-containing vacuole (SVC).
CC Alteration of the phosphoinositide composition of the plasma membrane
CC causes membrane ruffling and actin cytoskeleton rearrangements. The
CC persistence of PtdIns 3-P diverts the SCV from the endocytic pathway
CC resulting in enlarged vesicles, which are essential to create a
CC favorable environment where Salmonella can replicate and avoid immune
CC defenses of the host cells. {ECO:0000269|PubMed:9826652}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Note=Secreted via the
CC type III secretion system 1 (SPI-1 TTSS). {ECO:0000250}.
CC -!- DOMAIN: Contains the consensus sequence Cys-X(5)-Arg characteristic of
CC Mg-independent phosphatases.
CC -!- SIMILARITY: Belongs to the phosphatase IpgD/SopB family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U90203; AAB68660.1; -; Genomic_DNA.
DR EMBL; AF060858; AAC33723.1; -; Genomic_DNA.
DR EMBL; AF231141; AAF43686.1; -; Genomic_DNA.
DR AlphaFoldDB; O34105; -.
DR SMR; O34105; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0016791; F:phosphatase activity; IEA:InterPro.
DR InterPro; IPR008108; IpgD/SopB.
DR Pfam; PF05925; IpgD; 1.
DR PRINTS; PR01734; TYPE3OMBPROT.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Hydrolase; Secreted; Virulence.
FT CHAIN 1..561
FT /note="Inositol phosphate phosphatase SopB"
FT /id="PRO_0000220491"
FT MOTIF 460..466
FT /note="CX5R motif"
FT ACT_SITE 460
FT /evidence="ECO:0000255"
FT MUTAGEN 460
FT /note="C->S: Loss of activity."
FT /evidence="ECO:0000269|PubMed:9826652"
FT CONFLICT 163
FT /note="D -> V (in Ref. 3; AAF43686)"
FT /evidence="ECO:0000305"
FT CONFLICT 512..517
FT /note="PGDSEP -> LEIQKQ (in Ref. 3; AAF43686)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 561 AA; 61854 MW; 4B63C42ECA3595D0 CRC64;
MQIQSFYHSA SLKTQEAFKS LQKTLYNGMQ ILSGQGKAPA KAPDARPEII VLREPGATWG
NYLQHQKTSN HSLHNLYNLR RDLLTVGATV LGKQDPVLTS MANQMELAKV KADRPATKQE
EAAAKALKKN LIELIAARTQ QQDGLPAKEA HRFAAVAFRD AQDKQLNNQP WQTIKNTLTH
NGHHYTNTQL PAAEMKIGAK DIFPSAYEGK GVCSWDTKNI HHANNLWMST VSVHEDGKDK
TLFCGIRHGV LSPYHEKDPL LRQVGAENKA KEVLTAALFS KPELLNKALA GEAVSLKLVS
VGLLTASNIF GKEGTMVEDQ MRAWQSLTQP GKMIHLKIRN KDGDLQTVKI KPDVAAFNVG
VNELALKLGF GLKASDSYNA EALYQLLGND LRPEARPGGW VGEWLAQYPD NYEVVNTLAR
QIKDIWKNNQ HHKDGGEPYK LAQRLAMLAH EIDAVPAWNC KSGKDRTGMM DSEIKREIIS
LHQTHMLSAP GSLPDSGGQK IFQKVLLNSG NPGDSEPNTG GAGNKVMKNL SPEVLNLSYQ
KRVGDENIWQ SVKGISSLIT S